Work

Novel Spiroisatin Derivatives Potentially Useful for Preventing Myocardial Reperfusion Injury

Year: 2026
Type: article
Abstract: Ischemia−reperfusion injury remains a major clinical challenge due to mitochondrial dysfunction and cell death. Here we report a novel series of spiroisatin derivatives as modulators of the mitochondrial permeability transition pore (mPTP) targeted at the c-ring of F1/FO-ATP synthase. Structure−activity relationship analysis identified compound 15j with nanomolar in vitro potency in inhibiting mPTP opening while preserving ATP production. Molecular modeling supported distinct binding interactions within the c subunit of F1/FO-ATP synthase, rationalizing observed pharmacodynamics. Beyond mPTP inhibition, 15j positively modulates mitochondrial quality control pathways, including mitophagy and biogenesis, contributing to sustained mitochondrial homeostasis after reperfusion. These findings establish spiroisatin derivatives as a promising class of cardioprotective agents acting through convergent mechanisms on mitochondrial integrity and quality control.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W7235255846
FWCI:
Cites: 93
Cited by:
Related to: 10
Parts: 5